title: An orthotopic bladder cancer model for gene delivery studies.
abstract: Bladder cancer is the second most common cancer of the urogenital tract and novel therapeutic approaches that can reduce recurrence and progression are needed. The tumor microenvironment can significantly influence tumor development and therapy response. It is therefore often desirable to grow tumor cells in the organ from which they originated. This protocol describes an orthotopic model of bladder cancer, in which MB49 murine bladder carcinoma cells are instilled into the bladder via catheterization. Successful tumor cell implantation in this model requires disruption of the protective glycosaminoglycan layer, which can be accomplished by physical or chemical means. In our protocol the bladder is treated with trypsin prior to cell instillation. Catheterization of the bladder can also be used to deliver therapeutics once the tumors are established. This protocol describes the delivery of an adenoviral construct that expresses a luciferase reporter gene. While our protocol has been optimized for short-term studies and focuses on gene delivery, the methodology of mouse bladder catheterization has broad applications.
authors: Department of Microbiology & Immunology, Medical University of South Carolina.
authors: Laura
authors: L
authors: Kasman
authors: Christina
authors: C
authors: Voelkel-Johnson
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics; D008156:Luciferases / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics; D008163:Luminescent Measurements / Q000379:methods; D008297:Male; D051379:Mice; D019076:Transgenes; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D014546:Urinary Catheterization / Q000379:methods*
chemical_list: D008156:Luciferases